Former Purdue Execs Fight Exclusion From Gov't Programs After OxyContin Case
Executive Summary
The three former Purdue Pharma executives who pled guilty to misbranding OxyContin are battling the government for the ability to work in the health care sector. They have sued HHS for barring them from participation in government health programs for 12 years
You may also be interested in...
FDA Posts Criteria For Targeting Executives As Responsible Officers
FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.
FDA Posts Criteria For Targeting Executives As Responsible Officers
FDA publishes criteria for filing criminal misdemeanor charges against executives from firms that break food and drug laws almost a year after the agency signaled its intent to pursue such cases.
Still Guilty: Three Former Purdue Execs Lose Fight To Overturn Their Exclusion From Gov't Programs
"As with plaintiffs' repeated attempts to characterize themselves as innocent third parties to Purdue's misbranding, the court finds plaintiffs' arguments with respect to financial loss reflective of a fundamental misconception of their own plea agreements," the ruling states.